HIT Consultant September 10, 2025
What You Should Know:
– Proscia®, a pathology AI company, has announced the launch of Proscia Aperture™, a new precision medicine solution designed to automatically identify eligible patients for clinical trials at the moment of diagnosis.
– The AI-powered tool aims to tackle one of healthcare’s most significant challenges: connecting patients with life-saving therapies and accelerating the development of new treatments.
Transforming Pathology Data Into Real-Time Insights
Despite major advancements in medicine, fewer than one in ten cancer patients enroll in clinical trials, and many miss out on potentially life-saving therapies. While laboratories hold a unique position at the intersection of pathology, molecular, and clinical data, this wealth of information has largely been disconnected from the drug development...
Today's Sponsors
Today's Sponsor